NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

And if we are under a term sheet for a buyout do you think the buyer cares about a journal article?

well the new owner would, of course, be happy if the trial results were explained in a top-tier journal but it's no deal-breaker whatsoever. Approval is. It's all about the egos of some that it perse must be published in a top-tier journal where, obviously, they are being hindered/having trouble getting it published in. Meanwhile, patients are suffering and left in uncertainty if the drug works or not.

Any normal thinking management would have pulled after the second sign of delay and published in a less prestigious journal. But not this management. They will try with NEJM/Lancet if it will take another 100 years.

Alas NWBO does not have such management.